GlassScriptPhysician profile
Thomas C Suchy
NPI 1477999456
$28,836.92
in general payments reported to CMS, 2019-2025
31 companies · $1,750 in 2025
The $1,750 reported for 2025 was more than what 75% of Interventional Pain Medicine providers received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,030 · 2020: $4,334 · 2021: $3,438 · 2022: $2,895 · 2023: $4,548 · 2024: $8,842 · 2025: $1,750.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,468 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $5,631 · Travel and Lodging: $2,040.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,468.12 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $5,631.25 |
| Travel and Lodging | $2,040.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $18,255.16 | 2019-2025 | Proclaim, Octrode, Eterna |
| Nevro Corp. | $3,342.27 | 2019-2024 | Senza |
| Relievant Medsystems, INC. | $1,414.91 | 2023 | Intracept |
| Boston Scientific Corporation | $1,365.94 | 2019-2025 | General - Pain Management, Intracept, Wavewriter Alpha Prime 16 |
| Vertos Medical, INC. | $1,265.28 | 2020-2024 | Mild Device Kit |
| Globus Medical, INC. | $649.75 | 2025 | Senza, Vyrsa V1, Nevro |
| Saluda Medical Americas, INC. | $444.06 | 2023-2025 | Evoke Scs, Evoke |
| Si-Bone, INC. | $348.71 | 2019-2025 | |
| Medtronic, INC. | $223.64 | 2021-2025 | Inceptiv, Intellis Adaptivestim, In.Pact Admiral |
| Medtronic USA, INC. | $191.68 | 2019 | |
| Spr Therapeutics, INC | $183.70 | 2023-2025 | Sprint Pns System |
| Trisalus Life Sciences, INC. | $173.09 | 2023-2025 | Trinav Infusion System |
| Mdd US Operations, LLC | $112.18 | 2019-2020 | |
| Tersera Therapeutics LLC | $90.43 | 2019 | |
| Axogen | $90.12 | 2023 | Avance Nerve Graft |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Foundation Fusion Solutions, LLC | $72.99 | 2024 | |
| Avanos Medical | $72.68 | 2025 | |
| Curonix LLC | $72.06 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Uswm, LLC | $61.91 | 2021 | |
| Ipsen Biopharmaceuticals, INC | $61.73 | 2020-2021 | |
| Collegium Pharmaceutical, INC. | $50.44 | 2023-2024 | Belbuca |
| Biohaven Pharmaceuticals, INC. | $45.51 | 2021 | |
| Biodelivery Sciences International, INC. | $45.15 | 2019-2021 | |
| Pfizer INC. | $41.18 | 2019-2021 | |
| Stimwave Technologies Incorporated | $36.69 | 2020-2021 | |
| Stryker Corporation | $30.39 | 2024 | Mild Device Kit |
| Almatica Pharma LLC | $22.93 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $20.77 | 2022 | |
| Pharmacyclics LLC, An Abbvie Company | $18.56 | 2020 | |
| Eisai INC. | $16.86 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $16.15 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Suchy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.